肝细胞癌和心力衰竭中的血分泌蛋白基因:并发症和生物功能探索
Lizhi Cao1, Xiaoying Wang2, Zhongping Ning2
1Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai, China; Department of Equipment, Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Province Hospital of Chinese Medicine), Nanjing, Jiangsu, China.
Molecular immunology
|November 5, 2025
概括
研究人员确定了三种与肝癌 (HCC) 和心力衰竭 (HF) 相关的血分泌蛋白基因 (FCN3,FAP,HMGB2). 德克萨米他和儿茶素显示出预防这两种疾病的潜力.
科学领域:
- 生物医学研究的研究.
- 基因组学就是基因组学.
- 心血管医学 心血管医学
背景情况:
- 调查肝细胞癌 (HCC) 和心力衰竭 (HF) 相关疾病之间的复杂关系.
- 了解血分泌蛋白在调解共同疾病机制中的作用.
研究的目的:
- 确定关键的血分泌蛋白基因,这些基因与HCC和HF的并发症有关.
- 发现这些相互关联的疾病的潜在治疗点和生物标志物.
主要方法:
- 权重基因同表达网络分析 (WGCNA).
- 不同基因表达分析.
- 深度学习技术用于基因识别.
主要成果:
- 鉴定了Ficolin-3 (FCN3),纤维细胞激活蛋白 (FAP) 和高流动性组盒子2 (HMGB2) 作为HCC-HF并发症中的关键基因.
- 证实了这些基因在疾病发病过程中的重要生物功能.
- 德克萨米他和甲基因成为预防高血压和高血压的潜在药理干预措施.
结论:
- 阐明了潜在的机制性途径,这些途径是HCC和HF并发症的基础.
- 确立了FCN3,FAP和HMGB2作为预后评估的新生物标志物.
- 突出了FCN3,FAP和HMGB2作为HCC和HF治疗的潜在治疗点.
相关概念视频
Cell Specific Gene Expression
16.2K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.2K
Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
529
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
529
Cardiomyopathy III: Hypertrophic Cardiomyopathy
387
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
387
Heart Failure II: Pathophysiology
699
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
699


